Cargando…

OR03-3 Impact of Continuous Glucose Monitoring (CGM) on Lifestyle Modifications in Individuals with Prediabetes

INTRODUCTION: Adherence to lifestyle modifications can prevent diabetes; however, this poses a challenge for most individuals. CGM is an effective tool for glycemic control and lifestyle modifications in patients with diabetes on insulin therapy. We explored the impact of CGM use in individuals with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khan, Shanzay, Muhammad, Chalak, Munir, Kashif, Patel, Alpa, Patel, Amani, Rabiei-Flori, Elham, Reddy, Rashmi, Farhan, Hisham
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Diabetes & Glucose Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624677/ http://dx.doi.org/10.1210/jendso/bvac150.724

Ejemplares similares

THU316 Relatively Rare And Increasingly Fatal; A Case Of Euglycemic DKA In A Patient With Gestational Diabetes
por: Dimech, Christina, et al.
Publicado: (2023)

LBODP063 The Benefits Of Using Cgm For Intravenous Insulin Therapy
por: Bublik, Evgeniya, et al.
Publicado: (2022)

SAT134 CGM Use During Pregnancy Complicated By CF-Induced Diabetes
por: Mazori, Alon Y, et al.
Publicado: (2023)

PSUN229 Transitions of Care and Readmissions in Patients with Diabetes Receiving CGM at Hospital Discharge
por: Barnett, Anne, et al.
Publicado: (2022)

SAT115 Diabetes In Pregnancy: Evaluating Access And Usage Of Continuous Glucose Monitors (CGM) In A Medicaid Population
por: Chilukuri, Pranaya, et al.
Publicado: (2023)

ODP210 Impact of Continuous Glucose Monitoring (CGM) in the Intensive Care Units (ICUs): Accuracy, Reliability, Feasibility and Nurse Acceptance
por: del Rincon, Juan, et al.
Publicado: (2022)

Online Education Improves Knowledge and Confidence Related to CGM and the AGP
por: Larkin, Amy, et al.
Publicado: (2021)

The CGM Experience of Minority Adults With Type 1 Diabetes in the South Bronx
por: Lozada Orquera, Faustina Alejandra, et al.
Publicado: (2021)

ODP211 Impact of Race and Chronic Kidney Disease on the Correlation between HbA1c and Continuous Glucose Monitoring (CGM) Glycemic Measures
por: Kaplan, Leah, et al.
Publicado: (2022)

SUN-146 Glucose Clearance (GLCL) Using Continuous Glucose Monitoring (CGM)
por: Melish, John
Publicado: (2019)

SAT099 Should We Use HbA1c Or Continuous Glucose Monitoring (CGM) For Treatment Adjustment In Type 2 Diabetes Non-insulin Treated Patients?
por: Totomirova, Tzvetelina, et al.
Publicado: (2023)

FRI664 The Impact Of Prediabetes Diagnosis On The Prevalence Of Postbariatric Hypoglycemia
por: Reshma Shariff, Julia Rose, et al.
Publicado: (2023)

SAT-649 Comparison of the Accuracy and Concordance of 3 CGM Devices vs SMBG During Aerobic Exercise
por: Henske, Joseph A, et al.
Publicado: (2020)

MON-LB114 CGM in Cystic Fibrosis Patients to Predict Cystic Fibrosis-Related Diabetes Onset
por: Mei Hsia Pu, Mariana Zorron, et al.
Publicado: (2020)

THU306 Association Of Prediabetes With Cardiovascular Outcomes Among Veterans With Obesity
por: Pendse, Jay, et al.
Publicado: (2023)

THU358 A Case Of Latent Autoimmune Diabetes In Adults (LADA) Managed By Lifestyle And Dietary Intervention Alone
por: Waseem Ahmad, Malik, et al.
Publicado: (2023)

LBSUN307 A Randomized Controlled Pilot Study Of The Food Order Behavioral Intervention In Prediabetes
por: Shukla, Alpana P, et al.
Publicado: (2022)

LBODP056 Factors That Associate With Under-diagnosing Prediabetes In Primary Care: A Retrospective Study
por: Nguyen, An V, et al.
Publicado: (2022)

LBSUN211 The Importance Of Early Opportunities To Identify And Treat Prediabetes Or Even Change The Diagnostic Threshold For Diabetes
por: Schwartz, Stanley S, et al.
Publicado: (2022)

OR28-1 Racial and Ethnic Disparities in Diabetes Technology Use amongst Persons with Type 1 Diabetes
por: Alzedaneen, Yazan, et al.
Publicado: (2022)

THU303 The Associations Between Rest-Activity Parameters, Sleep-Disordered Breathing Severity And Glucose Metabolism In Patients With Prediabetes
por: Paewponsong, Jirayupa, et al.
Publicado: (2023)

PSUN192 Therapeutic Benefit of GLP-1 Agonists in Patients with Type 1 Diabetes on Insulin Therapy: an Updated Systematic Review and Meta-analysis
por: Park, Jeayoung, et al.
Publicado: (2022)

OR03-4 Efficacy and Safety of Avexitide for Treatment of Hypoglycemia after Gastrointestinal Surgery; Assessment of Novel Dosing Regimens in an Expanded Indication
por: Craig, Colleen, et al.
Publicado: (2022)

SAT-126 The Relationship of Continuous Glucose Monitoring (CGM)-Derived Time-in-Range (TIR) to Hemoglobin A1c (HbA1c)
por: Vigersky, Robert, et al.
Publicado: (2019)

OR12-03 The Pancreatic Islet Alpha Cell Arginine Transporter SLC7A2 Regulates Arginine-induced Glucagon Secretion and Glycemia
por: Stanley, Jade E, et al.
Publicado: (2023)

OR03-5 Identification of Four New Glucotypes during the First Year after Type 1 Diabetes Onset Using Continuous Glucose Monitoring Metrics
por: Delfosse, Antoine, et al.
Publicado: (2022)

OR18-03 Peripheral But Not Hepatic Insulin Resistance Associates With Adverse Vascular And Metabolic Health In Type 1 Diabetes: A Possible Target For Adjunctive Therapy
por: Snaith, Jennifer R, et al.
Publicado: (2023)

SAT133 A Case Study Of UX/UI Design Diabetes Medication Discharge Orderset: An Initiative To Reduce Discharge Prescribing Error
por: Yunasan, Elvina, et al.
Publicado: (2023)

OR34-03 Defining Clinical Characteristics Of Patients With Severe Hypoglycemia After Roux-en-Y Gastric Bypass: How Do They Differ From Asymptomatic Patients?
por: Grover, Ashna, et al.
Publicado: (2023)

ODP203 Health Questionnaires are a Positive Behavioral Modifier In Patients with Impaired Blood Sugar In the African American Population.
por: Patel, Krish, et al.
Publicado: (2022)

OR03-1 Achievement of HbA1c <6.5% without weight gain and hypoglycemia in people with type 2 diabetes treated with tirzepatide across the phase 3 SURPASS program
por: Allen, Sheryl Elaine, et al.
Publicado: (2022)

OR03-2 Phase 1, Randomized, Controlled Trial of GFB-024, a Once-Monthly CB1 Inverse Agonist, in Healthy Overweight and Obese Participants and in Participants with Type 2 Diabetes Mellitus
por: Bilic, Sanela, et al.
Publicado: (2022)

LBODP051 Relation Of The Quadrumvirate ― Hepatic Steatosis, High Normal Fasting Glucose, And Attenuated Whole Body-insulin Sensitivity And Glucose-stimulated Acute Insulin Secretion ― To Incident Prediabetes, The Beginning Of Type 2 Diabetes
por: Nakasone, Yasuto, et al.
Publicado: (2022)

OR03-6 Further Clinical Evaluation of Stem Cell-Derived Islet Replacement Therapy (VC-02) Demonstrates Production of C-Peptide with Improvements in Glycemic Control Parameters in Multiple Patients with Type 1 Diabetes and Hypoglycemia Unawareness
por: Bellin, Melena, et al.
Publicado: (2022)

MON-LB109 Transcutaneous Magnetic Stimulation: A Novel Treatment of Diabetic Peripheral Neuropathy
por: Satyarengga, Medha, et al.
Publicado: (2020)

Evaluation of Small Fiber Peripheral Neuropathy With Infrared Thermographic Camera in Prediabetes
por: Vasconcellos, Larissa Frazao, et al.
Publicado: (2021)

PSUN250 Empagliflozin Induced Bladder Cancer in an Adult Patient With Latent Autoimmune Diabetes
por: Alzenaidi, Ahlam, et al.
Publicado: (2022)

ODP202 Geriatric Type 1 Diabetes- unique management challenge
por: Patel, Toral, et al.
Publicado: (2022)

LBSAT236 A Case of Immune Checkpoint Inhibitor Pembrolizumab Induced Simultaneous Rare Endocrinopathies, Type 1 DM (presenting As DKA) And Grave's Thyrotoxicosis, With Evidence Of Autoimmunity Development.
por: Arora, Gunjan, et al.
Publicado: (2022)

ODP194 EPC (Epilepsia Partialis Continue)- as a presenting symptom of HHS (Hyperglycemic Hyperosmolar Syndrome)
por: Patel, Toral, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t4lqaqefigtve947dbgd9qsbum